Kiniciti

Kiniciti is a buy-and-build investment platform that partners with and invests in non-therapeutic service, tools, and technology companies to support and enable innovation in the cell and gene therapy (CGT) industry. The firm's investment focus includes companies with capabilities in cell engineering, gene-editing, cell sources, process development and scale-up tools, and production technologies. It was formed as a strategic partnership with private equity firm Welsh, Carson, Anderson & Stowe (WCAS) and is also backed by Biospring Partners.